Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    abt700
Show Display Options
Rank Status Study
1 Active, not recruiting Study of ABT-700 in Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: ABT-700;   Drug: docetaxel;   Drug: FOLFIRI;   Drug: cetuximab;   Drug: erlotinib

Study has passed its completion date and status has not been verified in more than two years.